Clinical Trial Update: Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two-drug vs four-drug chemotherapy regimens in advanced urothelial cancer (bladder cancer and related urothelial cancers) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter
• Urethral Cancer

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 3 | Status: COMPLETED